Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Current Assets
Cash and cash equivalents	$ 66,785	$ 17,996
Accounts receivable, net of allowances of $334 and $235, respectively	3,432	1,739
Notes and other receivables	888	152
Inventory, net of reserve of $437 and $138, respectively	1,540	1,243
Short-term investments	43,223	7,998
Prepaid expenses and other current assets	1,120	1,197
Total Current Assets	116,988	30,325
Property and equipment, net	1,483	1,445
Operating lease right-of-use asset, net	1,587	2,077
Software development costs, net	1,893	1,721
Investments in equity securities	7,655	0
Long-term investments	2,500	2,500
Intangible assets, net	34,775	14,203
Goodwill	24,017	6,588
Other assets	139	152
Total Assets	191,037	59,011
Current Liabilities
Accounts payable	1,394	908
Accrued liabilities	6,623	2,739
Income tax liabilities	3,509	0
Operating lease obligation, current	587	647
Deferred revenue	4,474	1,922
Short-term debt	3,251	5,401
Acquisition liability	336	500
Total Current Liabilities	20,174	12,117
Long Term Liabilities
Operating lease obligation, noncurrent	1,030	1,457
Other liabilities, noncurrent	28	7
Acquisition liability, noncurrent	5,425	750
Total Liabilities	26,657	14,331
Commitments and Contingencies
Stockholders’ Equity
Common Stock - $0.001 par value; 250,000,000 shares authorized; 124,593,720 and 53,178,462 issued and 124,593,719 and 53,178,461 outstanding as of September 30, 2021 and December 31, 2020, respectively.	125	53
Additional paid-in capital	335,940	225,613
Treasury stock, at cost, 1 share	(695)	(695)
Accumulated other comprehensive (loss) income	(352)	660
Accumulated deficit	(212,593)	(180,992)
Stockholders’ Equity Attributable to Inpixon	122,425	44,639
Non-controlling Interest	2,460	41
Total Stockholders’ Equity	124,885	44,680
Total Liabilities, Mezzanine Equity and Stockholders’ Equity	191,037	59,011
Series 7 Convertible Preferred Stock
Mezzanine Equity
Series 7 Convertible Preferred Stock - 58,750 shares authorized; 49,250 and — issued and outstanding as of September 30, 2021 and December 31, 2020, respectively. (Liquidation preference of $49,250,000)	39,495	0
Series 4 Convertible Preferred Stock
Stockholders’ Equity
Preferred stock, value, issued	0	0
Series 5 Convertible Preferred Stock
Stockholders’ Equity
Preferred stock, value, issued	$ 0	$ 0